Amgen Stock Target Price and Analyst Consensus
AMGN Stock | USD 269.98 0.60 0.22% |
The current analyst and expert consensus on Amgen is Buy with 13 hold recommendations. The current projected Amgen target price consensus is 258.80 with 30 analyst opinions. One of the most common ways Amgen Inc analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Amgen vendors, executives, and/or customers. Amgen recommendation module provides expert sentiment on the projected Amgen Inc target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Amgen to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 235.51 | Highest Forecast 287.27 | Target Price 258.8 |
Amgen |
It's important to approach Amgen's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Amgen Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amgen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Amgen's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
30 | Buy |
Most Amgen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Amgen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Amgen Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAmgen Target Price Projection
Amgen's current and average target prices are 269.98 and 258.80, respectively. The current price of Amgen is the price at which Amgen Inc is currently trading. On the other hand, Amgen's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Amgen Target Price
Amgen Analyst Ratings
Amgen's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Amgen stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Amgen's financials, market performance, and future outlook by experienced professionals. Amgen's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Amgen price targets
Amgen's stock target price is an estimate of its future price, usually made by analysts. Using Amgen's target price to determine if it is a suitable investment can be done through the following steps:- Look at Amgen's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Amgen's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Amgen Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amgen is a key component of Amgen valuation and have some predictive power on the future returns of a Amgen.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amgen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Dividend Beast Invested over 60 shares | ||
Hedge Favorites Invested over 100 shares | ||
Investor Favorites Invested few shares | ||
Baby Boomer Prospects Invested over 40 shares | ||
Momentum Invested over 200 shares | ||
Driverless Cars Invested over 200 shares | ||
Chemicals Invested over 40 shares | ||
Adviser Favorites Invested few shares | ||
FinTech Invested over 40 shares | ||
Check out Macroaxis Advice on Amgen to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Transaction History View history of all your transactions and understand their impact on performance |
The data published in Amgen's official financial statements usually reflect Amgen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amgen Inc. For example, before you start analyzing numbers published by Amgen accountants, it's critical to develop an understanding of what Amgen's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Amgen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amgen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amgen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amgen Inc. Please utilize our Beneish M Score to check the likelihood of Amgen's management manipulating its earnings.